Protein detail
EF2
Elongation factor 2 (EF-2) (EC 3.6.5.-)
Entry name EF2 | UniProt ID | EVMP confidence score 0.88 |
Supporting publications (n) 35 | Transmembrane count | Protein classification Cancer-related genesDisease related genesEssential proteinsFDA approved drug targetsHuman disease related genesMetabolic proteinsPlasma proteinsPredicted intracellular proteins |
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30Basic Information
Protein Names
Elongation factor 2 (EF-2) (EC 3.6.5.-)
Protein Class (8)
Cancer-related genesDisease related genesEssential proteinsFDA approved drug targetsHuman disease related genesMetabolic proteinsPlasma proteinsPredicted intracellular proteins
Protein Function (5)
- Predicted intracellular proteins
- Human disease related genes:Nervous system diseases:Neurodegenerative diseases
- Cancer-related genes:Candidate cancer biomarkers
- Disease related genes
- FDA approved drug targets:Biotech drugs
Ensembl
Entrez Gene Symbol
Gene Synonym (2)
EEF-2EF2
Gene Description
Eukaryotic translation elongation factor 2
Chromosome
19
Position
3976056-3985463
Supporting publications (n)
35
EVMP confidence score
0.88
Fluorescence & Localization
Tissue Specificlymphoid tissueCell SpecificAstrocytesSingle-Nuclei Brain SpecificleukocyteBlood Cell SpecificbasophilBlood Lineage Specificgranulocytes
Function & Pathway
Protein Function (5)
- Predicted intracellular proteins
- Human disease related genes:Nervous system diseases:Neurodegenerative diseases
- Cancer-related genes:Candidate cancer biomarkers
- Disease related genes
- FDA approved drug targets:Biotech drugs
Cellular Component (13)
- GO:0005576 extracellular region
- GO:0005634 nucleus
- GO:0005737 cytoplasm
- GO:0005829 cytosol
- GO:0005840 ribosome
- GO:0005886 plasma membrane
- GO:0016020 membrane
- GO:0016235 aggresome
- GO:0034774 secretory granule lumen
- GO:0045202 synapse
Page 1 of 2
Molecular Function (8)
Biological Process (3)
Reactome (12)
- R-hsa-9824439 bacterial infection pathways
- R-hsa-156842 eukaryotic translation elongation
- R-hsa-163841 gamma carboxylation hypusinylation hydroxylation and arylsulfatase activation
- R-hsa-5663205 infectious disease
- R-hsa-168249 innate immune system
- R-hsa-6798695 neutrophil degranulation
- R-hsa-597592 post translational protein modification
- R-hsa-8876725 protein methylation
- R-hsa-5358493 synthesis of diphthamide eef2
- R-hsa-72766 translation
Page 1 of 2
Mediation Categories (3)
Clinical-translation mediationImmune mediationMetabolism mediation
Relations & Evidence51
Enzyme-Mediated Modification (23)
23 records.
| Substrate Gene Symbol | Enzyme Gene Symbol | Enzyme UniProt ID | Residue Type | Residue Offset | Modification | Database | References |
|---|---|---|---|---|---|---|---|
| EEF2 | CAMK2G | Q13555 | T | 57 | phosphorylation | Sparser_ProtMapperProtMapper | ProtMapper:7548224 |
| EEF2 | CA2 | P00918 | T | 57 | phosphorylation | Sparser_ProtMapperProtMapper | ProtMapper:7548224 |
| EEF2 | GKN2 | Q86XP6 | T | 57 | phosphorylation | Sparser_ProtMapperProtMapper | ProtMapper:27499441 |
Page 3 of 3Previous
Ligand-Receptor Signaling (8)
8 records.
| Category | Parent | Database | Transmitter | Receiver | Secreted | Plasma Membrane (Transmembrane) | Plasma Membrane (Peripheral) |
|---|---|---|---|---|---|---|---|
| receptor | receptor | OmniPath | Yes | ||||
| extracellular | extracellular | OmniPath | |||||
| intracellular | intracellular | LOCATE | |||||
| intracellular | intracellular | ComPPI | |||||
| intracellular | intracellular | GO_Intercell | |||||
| intracellular | intracellular | UniProt_location | |||||
| intracellular | intracellular | OmniPath | |||||
| receptor | receptor | scConnect | Yes |
Regulatory Interaction Network (5)
5 records.
Protein Complex Composition (14)
14 records.
| Component Name | Component Gene Symbols | Component UniProt ID | Stoichiometry | Database | Database IDs | References |
|---|---|---|---|---|---|---|
| ABHD11BCAT2EEF2KMTLMAN2YBEY | O15382P58557Q12907Q8NFV4Q96G04 | 0:0:0:0:0 | hu.MAP2 | |||
| DDX17DHX15EEF2 | O43143P13639Q92841 | 0:0:0 | hu.MAP2 | |||
| ATP6V1HEEF2PNPLA6TIMM9 | P13639Q8IY17Q9UI12Q9Y5J7 | 0:0:0:0 | hu.MAP2 | |||
| EEF2KMT | Q96G04 | 3 | PDB | PDB:8fzb |
Page 2 of 2Previous
Isolation & Detection Technology (1)
1 record.
| EV Isolation Method | Detection Method | Number of References | References |
|---|---|---|---|
| Differential Ultracentrifugation | Mass spectrometryR Sequencing | 1 | 37886648 |
Sequence, Structure & Domains
Sequences
Length
858
Mass
95,338
Sequence
MVNFTVDQIRAIMDKKANIRNMSVIAHVDHGKSTLTDSLVCKAGIIASARAGETRFTDTRKDEQERCITIKSTAISLFYELSENDLNFIKQSKDGAGFLINLIDSPGHVDFSSEVTAALRVTDGALVVVDCVSGVCVQTETVLRQAIAERIKPVLMMNKMDRALLELQLEPEELYQTFQRIVENVNVIISTYGEGESGPMGNIMIDPVLGTVGFGSGLHGWAFTLKQFAEMYVAKFAAKGEGQLGPAERAKKVEDMMKKLWGDRYFDPANGKFSKSATSPEGKKLPRTFCQLILDPIFKVFDAIMNFKKEETAKLIEKLDIKLDSEDKDKEGKPLLKAVMRRWLPAGDALLQMITIHLPSPVTAQKYRCELLYEGPPDDEAAMGIKSCDPKGPLMMYISKMVPTSDKGRFYAFGRVFSGLVSTGLKVRIMGPNYTPGKKEDLYLKPIQRTILMMGRYVEPIEDVPCGNIVGLVGVDQFLVKTGTITTFEHAHNMRVMKFSVSPVVRVAVEAKNPADLPKLVEGLKRLAKSDPMVQCIIEESGEHIIAGAGELHLEICLKDLEEDHACIPIKKSDPVVSYRETVSEESNVLCLSKSPNKHNRLYMKARPFPDGLAEDIDKGEVSARQELKQRARYLAEKYEWDVAEARKIWCFGPDGTGPNILTDITKGVQYLNEIKDSVVAGFQWATKEGALCEENMRGVRFDVHDVTLHADAIHRGGGQIIPTARRCLYASVLTAQPRLMEPIYLVEIQCPEQVVGGIYGVLNRKRGHVFEESQVAGTPMFVVKAYLPVNESFGFTADLRSNTGGQAFPQCVFDHWQILPGDPFDNSSRPSQVVAETRKRKGLKEGIPALDNFLDKL
3D Structural Models
3D Structure
Electron microscopy (18)
Domain & Motif Annotations
Domain (FT)
17..362; tr-type G
Protein Families (3)
- TRAFAC class translation factor GTPase superfamily
- Classic translation factor GTPase family
- EF-G/EF-2 subfamily
Sequence Similarities
Belongs to the TRAFAC class translation factor GTPase superfamily. Classic translation factor GTPase family. EF-G/EF-2 subfamily.
Clinical Relevance
Disease Involvement (5)
Cancer-related genesDisease variantFDA approved drug targetsNeurodegenerationSpinocerebellar ataxia
Related Diseases
Drug Targets
FDA approved drug targets
Drugs (18)
RESIMMUNELMB-100DANUSERTIBTAGRAXOFUSP-ERZSCYCLOHEXIMIDEOPORTUZUMAB MONATOX(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDECOMPOUND 38 [PMID: 20817473]LACTIMIDOMYCINMOXETUMOMAB PASUDOTOXSS1(DSFV)-PE38AMG-900MK-5108GSK1070916ILORASERTIBTOZASERTIBBI-847325DENILEUKIN DIFTITOX
Interaction Protein (2)
ENSG00000072506ENSG00000174444
Interaction Count
2
Interaction Dataset (2)
intact_biogridbiogrid_opencell
Supporting Publications35
| PMID | Title | Related sentences |
|---|---|---|
| 33304478 | The proteomic landscape of small urinary extracellular vesicles during kidney transplantation. | No related sentences available |
| 33309826 | Proteomic analysis of extracellular vesicles and conditioned medium from human adipose-derived stem/stromal cells and dermal fibroblasts. | No related sentences available |
| 33592500 | A Proteomic Approach to Understand the Clinical Significance of Acute Myeloid Leukemia-Derived Extracellular Vesicles Reflecting Essential Characteristics of Leukemia. | No related sentences available |
| 34064677 | Ubiquinone Metabolism and Transcription HIF-1 Targets Pathway Are Toxicity Signature Pathways Present in Extracellular Vesicles of Paraquat-Exposed Human Brain Microvascular Endothelial Cells. | No related sentences available |
| 34473505 | Column-based Technology for CD9-HPLC Immunoaffinity Isolation of Serum Extracellular Vesicles. | Column-based Technology for CD9-HPLC Immunoaffinity Isolation of Serum Extracellular Vesicles. |
| 34576246 | Burn Injury Induces Proinflammatory Plasma Extracellular Vesicles That Associate with Length of Hospital Stay in Women: CRP and SAA1 as Potential Prognostic Indicators. | No related sentences available |
| 36064647 | Systemic proteomics and miRNA profile analysis of exosomes derived from human pluripotent stem cells. | No related sentences available |
| 36146834 | Human Cytomegalovirus Modifies Placental Small Extracellular Vesicle Composition to Enhance Infection of Fetal Neural Cells In Vitro. | No related sentences available |
| 36497184 | Oxidative Stress and Extracellular Matrix Remodeling Are Signature Pathways of Extracellular Vesicles Released upon Morphine Exposure on Human Brain Microvascular Endothelial Cells. | No related sentences available |
| 37204515 | Proteomic profiling and functional characterization of serum-derived extracellular vesicles in the mucinous and non-mucinous colon adenocarcinoma. | No related sentences available |